DE69122298D1 - Behandlung von Clostridium difficile Diarrhöe und pseudomembraner Dickdarmentzündung - Google Patents

Behandlung von Clostridium difficile Diarrhöe und pseudomembraner Dickdarmentzündung

Info

Publication number
DE69122298D1
DE69122298D1 DE69122298T DE69122298T DE69122298D1 DE 69122298 D1 DE69122298 D1 DE 69122298D1 DE 69122298 T DE69122298 T DE 69122298T DE 69122298 T DE69122298 T DE 69122298T DE 69122298 D1 DE69122298 D1 DE 69122298D1
Authority
DE
Germany
Prior art keywords
pseudomembrane
treatment
clostridium difficile
colon inflammation
difficile diarrhea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69122298T
Other languages
English (en)
Other versions
DE69122298T2 (de
Inventor
Itsuki Fujita
Nobuhiro Taguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MIYARISAN SEIBUTSU IGAKU KENKY
Original Assignee
MIYARISAN SEIBUTSU IGAKU KENKY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MIYARISAN SEIBUTSU IGAKU KENKY filed Critical MIYARISAN SEIBUTSU IGAKU KENKY
Publication of DE69122298D1 publication Critical patent/DE69122298D1/de
Application granted granted Critical
Publication of DE69122298T2 publication Critical patent/DE69122298T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69122298T 1990-05-07 1991-05-02 Behandlung von Clostridium difficile Diarrhöe und pseudomembraner Dickdarmentzündung Expired - Fee Related DE69122298T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2117267A JP2961184B2 (ja) 1990-05-07 1990-05-07 クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物

Publications (2)

Publication Number Publication Date
DE69122298D1 true DE69122298D1 (de) 1996-10-31
DE69122298T2 DE69122298T2 (de) 1997-02-06

Family

ID=14707530

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69122298T Expired - Fee Related DE69122298T2 (de) 1990-05-07 1991-05-02 Behandlung von Clostridium difficile Diarrhöe und pseudomembraner Dickdarmentzündung

Country Status (6)

Country Link
EP (1) EP0456418B1 (de)
JP (1) JP2961184B2 (de)
KR (1) KR0149672B1 (de)
DE (1) DE69122298T2 (de)
ES (1) ES2091290T3 (de)
HU (1) HUT61464A (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000010581A1 (fr) * 1998-08-20 2000-03-02 Miyarisan Pharmaceutical Co., Ltd. Medicaments comprenant une combinaison d'une bacterie produisant de l'acide butyrique, et d'un constituant d'acide biliaire
JP4467190B2 (ja) 1998-11-09 2010-05-26 大陽日酸株式会社 酸素同位体重成分の濃縮方法および装置
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
JPWO2002080947A1 (ja) 2001-04-06 2004-07-29 株式会社京都動物検査センター 酪酸転化能を有する菌含有組成物及びそれを用いた消化管の乳酸過多及び大腸がんの予防・治療方法
EA017564B1 (ru) * 2007-09-12 2013-01-30 Тарганта Терапьютикс Корп. Способ ингибирования клостридиум диффициле введением оритаванцина
NZ618935A (en) 2010-08-04 2014-03-28 Karma Medical Prod Co Ltd Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
JP2014507481A (ja) 2011-03-09 2014-03-27 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 結腸微生物相移植のための組成物及び方法
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
BR112015011933A8 (pt) * 2012-11-23 2022-09-20 Seres Therapeutics Inc Composições bacterianas sinérgicas e métodos de produção e uso das mesmas
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
WO2014121304A1 (en) 2013-02-04 2014-08-07 Seres Health, Inc. Compositions and methods
KR102222273B1 (ko) 2013-02-04 2021-03-08 세레스 테라퓨틱스, 인코포레이티드 조성물 및 방법
US10076546B2 (en) 2013-03-15 2018-09-18 Seres Therapeutics, Inc. Network-based microbial compositions and methods
MX367109B (es) 2013-11-25 2019-08-05 Seres Therapeutics Inc Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
EP3212001A4 (de) 2014-10-31 2018-04-25 Whole Biome Inc. Verfahren und zusammensetzungen im zusammenhang mit mikrobieller behandlung und diagnose von störungen
CN107949391B (zh) 2015-05-14 2021-11-09 克雷斯顿沃控股公司 用于粪便菌群移植的组合物以及用于制备和使用它们的方法和用于递送它们的装置
ES2909456T3 (es) 2015-05-22 2022-05-06 Univ Arizona State Métodos para tratar el trastorno del espectro autista y síntomas asociados
WO2017033925A1 (ja) * 2015-08-24 2017-03-02 株式会社ヤクルト本社 酪酸産生菌
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
US11433102B2 (en) 2017-04-05 2022-09-06 Finch Therapeutics Holdings Llc Compositions and methods for treating Parkinson's disease (PD) and related disorders
WO2018218159A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
CN111328284A (zh) 2017-08-07 2020-06-23 芬奇治疗公司 用于维持和恢复健康的肠道屏障的组合物和方法
EP3668527A1 (de) 2017-08-14 2020-06-24 Seres Therapeutics, Inc. Zusammensetzungen und verfahren zur behandlung von cholestase
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CN107937305B (zh) * 2017-11-21 2021-04-23 湖北绿雪生物科技有限公司 一株耐丁酸、抗逆性强的丁酸梭菌菌剂及其应用
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
AU2019351017A1 (en) 2018-09-27 2021-04-29 Finch Therapeutics Holdings Llc. Compositions and methods for treating epilepsy and related disorders

Also Published As

Publication number Publication date
HUT61464A (en) 1993-01-28
EP0456418B1 (de) 1996-09-25
HU911188D0 (en) 1991-10-28
JP2961184B2 (ja) 1999-10-12
EP0456418A2 (de) 1991-11-13
JPH0413628A (ja) 1992-01-17
ES2091290T3 (es) 1996-11-01
KR910019640A (ko) 1991-12-19
EP0456418A3 (en) 1993-01-20
DE69122298T2 (de) 1997-02-06
KR0149672B1 (ko) 1998-10-15

Similar Documents

Publication Publication Date Title
DE69122298D1 (de) Behandlung von Clostridium difficile Diarrhöe und pseudomembraner Dickdarmentzündung
DE69220679D1 (de) Antibakterielles mittel und behandlung von gegenständen mit diesem
ATE238692T1 (de) Behandlung von obst und gemüse
DE69329848D1 (de) Poymerisationsverfahren und daraus hergestellte tonerzusammensetzungen
DE69014030T3 (de) Mittel für die Verhütung und Behandlung von Diarrhöe.
DE68909219D1 (de) Behandlung von obesitas.
DE69027227D1 (de) Feldprogrammierbare Logik und analoge integrierte Schaltung
DE69429619D1 (de) Behandlung von neuromusculaeren stoerungen und zustaenden mit botulism serotyp e
DE69434734D1 (de) Modemanwendungen von gleichzeitiger analoger und digitaler Kommunikation
DE69115959D1 (de) Bleichende Verbindungen und Zusammensetzungen
DE69530860D1 (de) Behandlung der entzündung des sehnervs
ATA209789A (de) Behandlung von zementpulver
DE69430903T2 (de) Behandlung von periodontitis mit misoprostol
DE69429160T2 (de) Behandlung von textilprodukt
DE69100314D1 (de) Behandlung von Clostridium difficile Diarrhöe und Pseudomembrankolitis.
DE69316203T2 (de) Elektrochemische behandlung von oberflächen
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
FI941968A0 (fi) Rengas- ja hihnakoostumuksia
DE69427485D1 (de) Verbindungen, zubereitungen und behandlung von allergien und entzündungen
DE69405711D1 (de) Behandlung von rueckstandsoel
DE69303930D1 (de) Behandlung von mit quecksilber verunreinigtem schlamm
DE69132054T2 (de) Behandlung von windelausschlag
DE69325141D1 (de) Behandlung von lignozellulosehaltigen Materialien
DE69520268T2 (de) Behandlung von Legierungen und danach hergestellte Gegenstände
NO913661L (no) Anordning og fremgangsmaate for dosering av vaskemiddelkompositter.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee